08-2-19-5633.jpg

Advancing NEW Treatment for Osteoarthritis ​

    n-STRIDE AUTOLOGOUS PROTEIN SOLUTION (APS) TREATMENT

Intra-Articular Injection for the Treatment of Knee Osteoarthritis (OA)

 

Once the pain of osteoarthritis starts it is hard to stop. The n-STRIDE APS technology is designed to produce a ground-breaking autologous therapy to treat pain and slow the progression of cartilage degradation and destruction. The n-STRIDE APS technology is a cell-concentration system which concentrates anti-inflammatory cytokines and anabolic growth factors to significantly decrease pain and promote cartilage health

 

 

Pre-Clinical & Clinical

 

  • Significantly reduces pain associated with knee OA

  • Significantly improves function in the knee joint associated with OA

  • Stimulates cartilage cell proliferation

  • Blocks cartilage destruction

  • Slows cartilage degradation

  • Point of care

  • Single-injection treatment

 

 

nSTRIDE arthritis treatment Birmingham